Ailian Hua

Ailian Hua

Auto-generated profile, based on publicly available information

Ailian Hua

The First People’s Hospital of Hangzhou Linping District: Zhejiang University School of Medicine Second Affiliated Hospital Linping Hospital , Hang Zhou , China

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in Chemico-Biological Interactions
Verified
Journal Article
Open access
YZyunfang Zhou
yunfang Zhou
YTYingying Tu
Yingying Tu
QZQuan Zhou
Quan Zhou
AHAilian Hua
Ailian Hua
PGPeiwu Geng
Peiwu Geng
CWCongcong Wen
Congcong Wen
Acacetin is a natural flavonoid that is widely distributed in plants and possesses numerous pharmacological activities. The aim of the present study was to investigate the effects of acacetin on the activities of the cytochrome P450 family members CYP1A2, CYP2B1, CYP2C11, CYP2D1, CYP2E1, and CYP3A2 in rat liver microsomes in vitro and rats in vivo to evaluate potential herb-drug interactions by using a cocktail approach. Phenacetin, bupropion, tolbutamide, dextromethorphan, chlorzoxazone, and midazolam were chosen as the probe substrates. An ultra-performance liquid chromatography-tandem mass spectrometry method was developed for the simultaneous detection of the probe substrates and their metabolites. In vitro, the mode of acacetin inhibition of CYP2B1, CYP2C11, and CYP2E1 was competitive, while mixed inhibition was observed for CYP1A2 and CYP3A2. The Ki values in this study were less than 8.32 μM. In vivo, the mixed probe substrates were administered by gavage after daily intraperitoneal injection with 50 mg/kg acacetin or saline for 2 weeks. The main pharmacokinetic parameters, area under the plasma concentration-time curve (AUC), plasma clearance (CL), and maximum plasma concentration (Cmax) of the probe substrates were significantly different in the experimental group than in the control group. Overall, the in vitro and in vivo results indicated that acacetin would be at high risk to cause toxicity and drug interactions via cytochrome P450 inhibition.

30 November 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
SWshuanghu wang
shuanghu wang
XTXueying Tan
Xueying Tan
SLShujuan Li
Shujuan Li
YZyunfang Zhou
yunfang Zhou
PGPeiwu Geng
Peiwu Geng
ZYZhihong Yu
Zhihong Yu
Indomethacin-based stimuli-responsive micelles combined with paclitaxel to overcome multidrug resistance Indomethacin-based stimuli-responsive micelles combined with paclitaxel to overcome multidrug resistance

5 September 2018 in Thoracic Cancer
Verified
Journal Article
Open access
PDF file
QWQingjun Wu
Qingjun Wu
AHAilian Hua
Ailian Hua
YSYaoguang Sun
Yaoguang Sun
CMChao Ma
Chao Ma
WTWenxin Tian
Wenxin Tian
WQWeiwen Qiu
Weiwen Qiu
Background: AZD‐3759 is a new, potent, oral, active central nervous system‐penetrant EGFR inhibitor. Despite promising clinical activity among patients pretreated and never treated with EGFR‐tyrosine kinase inhibitors, no time saving pharmacokinetic study method has been reported in an animal model.Methods: Protein was precipitated with acetonitrile and then used for sample pre‐processing. A CORTECS BEH C18 column was used to separate the analytes at 40°C. Acetonitrile and water (containing 0.1% formic acid) were chosen as the mobile phase at a flow rate of 0.4 mL/min. The analytes were quantified by multiple reaction monitoring mode with positive electrospray ionization.Results: The target fragment ions were m/z 460.38→141 for AZD‐3759 and m/z 285.1→193.1 for internal standard diazepam. The calibration curve exhibited good linearity for AZD‐3759 at a range of 1–500 ng/mL. The intra‐run and inter‐run precision variations were both < 8.22%. The recovery rate of AZD‐3759 from plasma was > 76.4%.Conclusion: An accurate, simple ultra performance liquid chromatography with triple quadrupole mass spectrometer method was developed and validated to determine AZD‐3759 in rat plasma. Our validated method can be applied to the pharmacokinetic study of AZD‐3759 at an oral dosage of 10 mg/kg.

27 July 2020 in Records of Natural Products
Verified
Journal Article
Closed access
RYRong Yao
Rong Yao
SYShen Yao
Shen Yao
AHAilian Hua
Ailian Hua
Chemical investigation of the EtOAc extract of a marine-derived fungus Aspergillus versicolor SZW-5 led to the isolation of one new compound, named aspeverether A (1), and seven known compounds. The structures were determined by extensive analyses of spectroscopic data (1D and 2D NMR, and HRESIMS). Compounds 1 and 3 possessed an unusual 1,3-dimethoxy-2-vinylbenzene moiety, which is rarely found in nature. Compound 6 showed strong inhibitory effect toward a-glucosidase with an IC50 value of 71 mM, being more active than the positive acarbose (210 mM).

1 January 2024 in Postępy Higieny I Medycyny Doświadczalnej
Verified
Journal Article
Open access
PDF file
KWKaymin Wu
Kaymin Wu
YHYouWu He
YouWu He
AHAilian Hua
Ailian Hua
YYYi Yao
Yi Yao
Introduction: This study aimed to investigate the potential causal effects of plasma metabolites on skin cancer (SC) risk through a two-sample Mendelian randomization (MR) analysis. Skin cancer, including melanoma and non-melanoma types, is a prevalent malignancy worldwide, necessitating the identification of novel biomarkers for early detection and prevention. Materials and Methods: We utilized genome-wide association study (GWAS) data from 8,299 individuals of European ancestry in the Canadian Longitudinal Study of Aging (CLSA) cohort, encompassing 1,400 metabolites. The analysis also incorporated GWAS data from FinnGen, including 20,951 SC patients and 287,137 controls of European ancestry. The association between metabolites and SC risk was assessed using the inverse-variance weighted (IVW) method, complemented by sensitivity analyses such as MR-Egger and MR-PRESSO tests. Results: The results revealed significant associations between 78 unique metabolites and SC risk. Among these, 42 metabolites were associated with a significant increase in SC risk, while 36 metabolites were linked to a significant reduction in SC risk. Conclusions: This study highlights novel blood metabolites that are closely related to SC risk, emphasizing their potential importance in prioritizing metabolic features for SC mechanistic research. Further evaluation of these metabolites in SC risk assessment could lead to new insights into SC prevention and treatment strategies.